The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
Table 4
Clinical comparison of p-NBD and BD without neurological involvement.
Parameters
p-NBD ()
Controls¥ ()
value
OR (95% CI)
Age (years, )
0.601
1.01 (0.98-1.04)
Gender (F/M)
25/17
50/34
1.000
—
Clinical features of BD
Oral ulceration
42 (100%)
84 (100%)
1.000
—
Genital ulceration
27 (64.3%)
61 (72.6%)
0.337
0.68 (0.31-1.50)
Skin lesions
19 (45.2%)
40 (47.6%)
0.801
0.91 (0.43-1.91)
Gastrointestinal lesions
3 (7.1%)
17 (20.2%)
0.058
0.30 (0.08-1.10)
Ocular involvement·
15 (35.7%)
16 (19.0%)
0.041||
2.36 (1.03-5.44)
Vascular involvement
6 (14.3%)
10 (11.9%)
0.705
1.23 (0.42-3.66)
Laboratory tests
ESR (mm/h, median and range)
15 (0-85)
11 (1-80)
0.072
1.01 (0.99-1.03)
CRP (mg/L, median and range)
3.0 (0.14-124)
3.3 (0.13-104)
0.995
1.00 (0.98-1.02)
OR = odds ratio; CI = confidential interval. Values are the number (percentage) unless otherwise indicated. ¥Eighty-four age- and gender-matched BD patients without neurological involvement were served as control. ·Ocular involvement includes uveitis, retinal vasculitis, and scleritis. ||.
